SBT 16th Annual Meeting
Faculty
| Cheryl
Baker, PhD University of Texas, M.D. Anderson Cancer Center |
John
Leonard, MD Cornell University |
| Ronald
Bukowski, MD Cleveland Clinic |
Steven
K. Libutti, MD National Cancer Institute |
| Michael
Caligiuri, MD Ohio State University School of Medicine |
Brian
Link, MD University of Iowa |
| Peter
Choyke, MD National Institutes of Health, Clinical Center |
Lance
Liotta, MD, PhD National Cancer Institute |
| Benjamin
G. Cocks, PhD Incyte Genomics, Inc. |
Michael
Lotze, MD University of Pittsburgh |
| Thomas
Davis, MD Medarex, Inc. |
Marsha
Moses, PhD Harvard Medical School, Childrens Hospital |
| Theodore
DeWeese, MD Johns Hopkins Oncology Center |
James
Mulé, PhD University of Michigan Medical Center |
| Robert
O. Dillman, MD Hoag Cancer Center |
Michael
O'Reilly, MD University of Texas, M.D. Anderson Cancer Center |
| Mary
L. (Nora) Disis, MD University of Washington |
Karolina
Palucka, MD, PhD Baylor Institute for Immunology Research |
| Alexander
Eggermont, MD, PhD Rotterdam Cancer Institute |
Juha
Punnonen, MD, PhD Maxygen, Inc. |
| Terry
J. Fry, MD National Cancer Institute, Pediatric Oncology Branch |
Joseph
Rininger, PhD CuraGen Corporation |
| Stanton
Gerson, MD Case Western Reserve University |
Steven
Rosenberg, MD, PhD National Cancer Institute, Surgery Branch |
| Stephen
Gillies, PhD Lexigen Pharmaceuticals Corporation |
Craig
Slingluff, Jr., MD University of Virginia Health Sciences Center |
| Jared
Gollob, MD Beth Israel Deaconess Medical Center |
Paul
Sondel, MD, PhD University of Wisconsin |
| William
Haseltine, PhD Human Genome Sciences, Inc. |
Walter
Storkus, PhD University of Pittsburgh School of Medicine |
| Stephen
Hodi, MD Dana-Farber Cancer Institute |
David
Weng, MD, PhD Cleveland Clinic Foundation |
| Burkhard
Jansen, MD University of Vienna |
Jon
Wigginton, MD Center for Cancer Research National Cancer Institute |
| Javed
Khan, MD Advanced Technology Center |
Jerry
Zeldis, MD, PhD Celgene Corporation |
| Arthur
M. Krieg, MD Coley Pharmaceutical Group |
Robert
Zimmerman, SD Bayer Pharmaceutical Division |
